Laws, Regulations, and Guidelines
37%of exam
Inventory Management, Documentation, and Recordkeeping
35%of exam
Types of Suppliers and Supply Chain Entities
28%of exam
Quick Facts
- Exam
- PTCB Supply Chain Certificate
- Credential Type
- Assessment-Based Certificate (ABC)
- Questions
- 75 multiple-choice
- Exam Time
- 1h20m (1h30m total)
- Passing Score
- Scaled 300 of 0-400
- Exam Fee
- $89
- Renewal
- Not required (no expiration)
- Retake Wait
- None; ABCs have no wait
- Eligibility
- Active CPhT + REP program
T3 Data Memory Line
TI+TS required; TH sunset 2023
Transaction Info vs Statement
Transaction Information (TI)
- Product, lot, dates
- Data about the sale
Transaction Statement (TS)
- Seller's attestation
- Authorized, not altered, not suspect
Data vs sworn statement
Suspect Product Response
- Signs of counterfeit or diversion→Quarantine + investigate(Suspect product)
- Investigation confirms illegitimate→Notify immediate trading partners(Required step)
- Confirmed illegitimate product→Notify FDA within 24h(Section 582)
- Investigation clears the product→Return to saleable stock(Keep investigation records)
- Grey-market pricing spotted→Treat as suspect signal(Red flag)
- Poor package integrity→Quarantine before dispensing(Red flag)
FDA & DEA Roles
- FDA
- Drug safety, efficacy, security
- DEA
- Controlled substance safety, security
- State Board
- Licenses pharmacies, techs, in-state
- FDA Registration
- Register within 5 days
- FDA Annual Renewal
- Oct 1 to Dec 31
- DECRS
- Searchable, updated each business day
- WD State License
- State (or FDA) license required
- DEA Registration
- Per location, not company-wide
- PDMA (1987)
- State wholesaler licensing law
- Pedigree
- Drug's distribution history record
EDDS Phase-In Order
2023 legal; 2025 big; 2027 small
Form 222 vs CSOS
Form 222
- Paper order form
- Schedule I-II only
CSOS
- Digital certificate order
- Schedule I-V, broader scope
Paper vs electronic scope
T3 Receiving Picker
- Accepting ownership of product→Require TI + TS first(At or before sale)
- Seller offers only history→TH alone is not enough(TH sunset 2023)
- Choosing transmission method→Electronic; GS1 EPCIS standard(Not fax/spreadsheet)
- Storing received T3 data→Retain records 6 years(Produce on request)
- Verifying product identifier→Check NDC + lot + serial(2D barcode)
DSCSA Basics
- DSCSA
- 2013 track-and-trace drug law
- Product
- Finished-dose Rx drug only
- Product Exclusions
- Blood, radioactive, gases, compounded
- Transaction
- Ownership change between parties
- Transaction Exclusions
- Intracompany, emergency, minimal office use
- Serialization
- NDC, serial, lot, expiry
- Trading Partner
- Manufacturer, repackager, wholesaler, dispenser, 3PL
Domain Weight Order
Laws 37 > Inventory 35 > Suppliers 28
Suspect vs Illegitimate Product
Suspect Product
- Reason to investigate
- Counterfeit, diverted, grey market
Illegitimate Product
- Confirmed unfit for distribution
- Notify partners + FDA 24h
Suspicion vs confirmed finding
T3 Data & Suspect Products
- TI
- Product + lot + dates
- TS
- Seller's authorization attestation
- TH
- Sunset requirement Nov 2023
- Receiving Rule
- Need TI+TS at transaction
- Exchange Method
- Electronic; GS1 EPCIS standard
- Retention
- Keep T3 data 6 years
- Suspect Signs
- Counterfeit, diverted, grey market, misbranded
- Illegitimate Step
- Notify partners + FDA 24h
Wholesale Distributor vs 3PL
Wholesale Distributor
- Takes title to drug
- Subject to 582 tracing
3PL
- Warehouses; no title transfer
- Excluded from 582 tracing
Ownership vs logistics only
DSCSA EDDS Timeline
- Legal Effect Date
- Nov 27, 2023
- Stabilization End
- FDA discretion ended Nov 2024
- Mfr/Repackager Exemption
- Ended May 27, 2025
- Wholesaler Exemption
- Ended Aug 27, 2025
- Large Dispenser Exemption
- Ended Nov 27, 2025
- Small Dispenser Exemption
- Extended to Nov 27, 2027
- Small Dispenser Size
- ≤25 FT pharmacists + technicians
Inventory Method Continuum
Want book -> Par -> JIT -> Perpetual
Controlled Substance Recordkeeping Picker
- Ordering Schedule I or II→Form 222 or CSOS(CSOS covers I-V)
- Theft or loss discovered→Notify DEA in 1 day(Then file Form 106)
- Filing the loss report→Electronic Form 106, 45 days(Paper form retired)
- Counting Schedule I or II→Exact count required(Biennial minimum)
- Counting Schedule III-V stock→Estimate unless over 1,000 tablets(Then exact count)
- Returning drugs for disposal→Send to reverse distributor(CII needs Form 222)
DEA Controlled Substance Records
- Form 222
- Paper order; Schedule I-II
- CSOS
- Electronic order, Schedule I-V
- CSOS Certs
- 21 CFR 1311 Subpart B
- Theft/Loss
- Notify DEA 1 business day
- Form 106
- File electronically, 45-day deadline
- Biennial Inventory
- New count every 2 years
- Exact vs Estimate
- Schedule I-II exact; III-V estimate
- Estimate Exception
- Exact if over 1,000 tablets/capsules
- Five Percent Rule
- Transfers ≤5% of annual dosage units
- Reverse Distributor
- Takes back expired or recalled
Records Retention Memory
DEA records 2yr; DSCSA data 6yr
Inventory Methods
- Want Book
- Manual, low-tech reorder note
- Par Level
- Target stock; often the max
- Just-in-Time
- Order arrives right before need
- Perpetual Inventory
- Real-time count every transaction
- Formulary
- Pre-approved stocking list
- Non-Formulary
- Needs prior authorization or order
- Seasonal Forecasting
- Predictable demand swings, e.g. flu
- Emergency Forecasting
- Unpredictable surge, e.g. disaster
- Automation
- ADCs, carousels, barcode scanning
- Turns Formula
- COGS divided by avg inventory
- Days' Supply Formula
- 365 divided by turns
Contracts & Sourcing
- Individual Contract
- Direct pharmacy-supplier negotiation
- GPO
- Pools volume for pricing
- Buying Group
- Smaller, formal pooled buying
- Consignment
- Supplier owns stock until used
- 340B GPO Rule
- DSH, cancer, children's hospitals barred
- State Vaccine (VFC)
- Segregate public stock from private
- 503A Alternate Source
- Compounded, patient-specific prescriptions
- White Bagging
- Outside pharmacy ships to provider
- Brown Bagging
- Patient carries drug to provider
- Clear Bagging
- Health system's own specialty pharmacy
503A vs 503B
503A Compounding
- State-licensed pharmacist pharmacy
- Patient-specific prescription needed
503B Outsourcing Facility
- FDA-registered, follows cGMP
- No patient prescription needed
Pharmacy vs outsourcing facility
Supply Chain Entity Picker
- Never touches the drug→Virtual manufacturer or wholesaler(Uses a 3PL or contractor)
- Warehousing, no title transfer→3PL(Excluded from 582 tracing)
- Outsourced sterile compounding needed→503B outsourcing facility(cGMP, FDA-registered)
- Patient-specific shortage workaround→503A compounded product(Inventory domain)
- High-cost limited-distribution drug→Specialty wholesale distributor(Often a Big Three affiliate)
- Buying nonprescription stock only→OTC-only distributor(No Rx authority)
Supply Chain Entities
- Manufacturer
- Holds approved drug application
- Repackager/Relabeler
- Repacks into new container
- Primary Wholesaler
- Buys direct from manufacturer
- Secondary Wholesaler
- Buys from other wholesalers
- Specialty Wholesaler
- High-cost, limited-distribution drugs
- OTC-Only Distributor
- Distributes nonprescription drugs only
- Virtual Manufacturer
- Never holds product physically
- Virtual Wholesaler
- Never possesses drug physically
- 3PL
- Warehouses, ships; no title transfer
- 3PL Tracing Scope
- Trading partner, excluded from 582
Primary vs Secondary Wholesaler
Primary Wholesaler
- Buys direct from manufacturer
- Largest volume distributors
Secondary Wholesaler
- Buys from other wholesalers
- Resupply and gap-filling role
Source vs resupply channel
503B & Cross-Border
- 503B Facility
- FDA-registered; follows cGMP rules
- 503B Copy Limit
- No essentially-a-copy compounding allowed
- 503B Wholesaling Limit
- Buyers cannot resell its products
- 503A Domain Placement
- Placed in Inventory domain
- Foreign Sourcing
- Extra verification, import controls apply
- Drug Transfer
- Physical drug moves, not Rx
- Transfer Definition
- Pharmacy-to-pharmacy physical movement only
Virtual Manufacturer vs Wholesaler
Virtual Manufacturer
- Holds the drug application
- Never possesses product physically
Virtual Wholesaler
- Meets wholesaler definition
- Never possesses drug physically
Owns license vs resells drug
Common Traps
TH required?
TH sunset Nov 2023 ≠ TI + TS still required
Effective vs enforced
Legal date Nov 2023 ≠ Enforcement phased to 2027
Form 222 vs CSOS scope
222 is Schedule I-II ≠ CSOS spans Schedule I-V
3PL role vs tracing
3PL is a trading partner ≠ 3PL excluded from 582 tracing
503A vs 503B domain
503A sits in Inventory ≠ 503B sits in Suppliers
GPO prohibition scope
DSH, cancer, children's hospitals ≠ Not all 340B entities
Par level vs min-max
Par is the target max ≠ Min-max sets reorder point
Last Minute
- 1.75 questions, 1h20m testing time
- 2.Passing scaled score is 300
- 3.Laws domain 37%, the largest
- 4.ABC = no renewal ever
- 5.Retake: no wait period
- 6.TH sunset 2023; TI+TS required
- 7.EDDS legal 2023; small-dispenser 2027
- 8.Form 222 = Schedule I-II
- 9.CSOS = Schedule I-V electronic
- 10.Turns = COGS / avg inventory
- 11.503A = Inventory domain, not Suppliers
- 12.3PL excluded from 582 tracing
Explore More PTCB Pharmacy Technician Certifications
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
More From This Family
Videos and articles for deeper review.